enfortumab vedotin: targeting bladder cancer
Published 6 years ago • 903 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
2:09
enfortumab vedotin for bladder cancer
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
0:50
enfortumab vedotin appears well-tolerated and active in advanced bladder cancers
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
2:52
enfortumab vedotin in urothelial cancer
-
3:24
enfortumab vedotin as treatment for urothelial carcinomas
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
1:14
bladder: enfortumab vedotin pembrolizumab & vesper trial
-
0:44
antibody-drug conjugates for advanced bladder cancer
-
13:47
ev-103: enfortumab vedotin and pembrolizumab in urothelial carcinoma
-
1:05
future endeavours with adcs in bladder cancer
-
2:25
unite: efficacy of enfortumab vedotin in advanced urothelial cancer
-
0:46
molecular markers guiding treatment approaches in bladder cancer
-
2:50
promising therapies for bladder cancer
-
4:21
sacituzumab govitecan plus enfortumab vedotin in advanced urothelial cancer